Zobrazeno 1 - 10
of 255
pro vyhledávání: '"Xianglin L Du"'
Publikováno v:
PLoS ONE, Vol 16, Iss 11, p e0260107 (2021)
ObjectivesThis post-trial data linkage analysis was to utilize the data of Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants linked with their Medicare data to examine the risk of hospitalized and non-h
Externí odkaz:
https://doaj.org/article/8c13057ef2a94c0191147151a426d094
Autor:
Dan Li, Xianglin L Du, Yinghong Ren, Peijun Liu, Shuting Li, Jiao Yang, Meng Lv, Ling Chen, Xin Wang, Enxiao Li, Jin Yang, Min Yi
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0156617 (2016)
Ethnic disparities in lung and bronchial cancer diagnoses and disease-specific survival (DSS) rates in the United States are well known. However, few studies have specifically assessed these differences in Asian subgroups. The primary objectives of t
Externí odkaz:
https://doaj.org/article/3eeefcb7b59645a9afca54dcfc00ac49
Autor:
Yu Ren, Dalliah M Black, Elizabeth A Mittendorf, Peijun Liu, Xu Li, Xianglin L Du, Jianjun He, Jin Yang, Kelly K Hunt, Min Yi
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e110281 (2014)
BackgroundPrevious studies found that the risk of breast cancer-related death is greater in estrogen receptor (ER)-negative disease than in ER-positive disease within 5 years of diagnosis, but greater for ER-positive disease than for ER-negative dise
Externí odkaz:
https://doaj.org/article/827844cc6b2446f8857a080b61504c6d
Autor:
Jessica Clague, Peggy Reynolds, Katherine D Henderson, Jane Sullivan-Halley, Huiyan Ma, James V Lacey, Shine Chang, George L Delclos, Xianglin L Du, Michele R Forman, Leslie Bernstein
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e103735 (2014)
Previous results from research on menopausal hormone therapy (MHT) and lung cancer survival have been mixed and most have not studied women who used estrogen therapy (ET) exclusively. We examined the associations between MHT use reported at baseline
Externí odkaz:
https://doaj.org/article/6b53d8fe0b814ff28eef0a5e708f6ac6
Autor:
Yijiong Yang, Stacy A. Drake, Jing Wang, Gordon C. Shen, Hongyu Miao, Robert O. Morgan, Xianglin L. Du, David R. Lairson
Publikováno v:
Aging Medicine, Vol 7, Iss 1, Pp 52-59 (2024)
Abstract Introduction Addressing femoral neck fractures resulting from ground‐level falls in older adults with Alzheimer's disease (AD) involves a personalized treatment plan. There is considerable ongoing debate concerning the relative advantages
Externí odkaz:
https://doaj.org/article/c782beb3a186422e86c05b1c44ae58f8
Autor:
Junghyun Kim, Man S. Kim, Suja S. Rajan, Xianglin L. Du, Luisa Franzini, Tae Gi Kim, Sharon H. Giordano, Robert O. Morgan
Publikováno v:
Current Oncology, Vol 30, Iss 4, Pp 3800-3816 (2023)
The purpose of this study is to examine the geographical patterns of adjuvant hormonal therapy adherence and persistence and the associated factors in insured Texan women aged 18–64 with early breast cancer. A retrospective cohort study was conduct
Externí odkaz:
https://doaj.org/article/73022fb7981d4d3dbb8fc6963d386ff9
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
PurposeTo explore whether prostate cancer incidence trends from 2000 to 2020 in the United States differed by race and ethnicity, age and tumor stage; to explore racial differences in prostate cancer incidence change due to the impact of COVID-19 pan
Externí odkaz:
https://doaj.org/article/d3ea54db6321450f90e46a0f80319c19
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
PurposeThis study aimed to determine the 18-year risk of cancer, angioedema, insomnia, depression, and erectile dysfunction in association with antihypertensive drug use.MethodsThis is a post-trial passive follow-up study of Antihypertensive and Lipi
Externí odkaz:
https://doaj.org/article/4976e1bc27654f699c01291dc165f61b
Autor:
Ping Zhu, Xianglin L. Du, Lu-yu Hwang, David Lairson, Ruosha Li, Yoshua Esquenazi, Jay-Jiguang Zhu
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract The optimal time to initiate adjuvant therapy (AT) in elderly patients with glioblastoma (GBM) remains unclear. We investigated the impact of timing to start AT on overall survival (OS) using two national-scale datasets covering elderly GBM
Externí odkaz:
https://doaj.org/article/893e9fdc2024472a979ae7cf6dde5c45
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundSeveral previous studies showed that patients who received angiotensin II–stimulating antihypertensive medications had a lower incident dementia rate than those angiotensin II–inhibiting antihypertensive users, but no study has been con
Externí odkaz:
https://doaj.org/article/3434118301064f779718d796770ea261